The microbiome sequencing service market enables characterization of microbial communities present in human body and other environmental samples using next generation sequencing technologies. Microbiome sequencing allows researchers to understand the role of microorganisms in human health and disease. Advantages of microbiome sequencing include providing deeper understanding of microbial diversity, species level profiling and taxonomic classification. The growing need to study gut-brain axis and role of microbiome in various diseases such as cancer, diabetes, obesity has created demand for microbiome sequencing services.

The Global microbiome sequencing service market is estimated to be valued at US$ 4.13 Bn in 2024 and is expected to exhibit a CAGR of 11.% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the microbiome sequencing service are Microbiome Insights Inc., Baseclear B.V., Clinical Microbiomics A/S, Mérieux NutriSciences Corporation, MR DNA, Zymo Research Corporation, Metabiomics Corp., uBiome, Inc., Microbiome Therapeutics Innovation Group, Locus Biosciences, Inc., OpenBiome, Shanghai Ruiyi Biotechnology Co., Ltd., Resphera Biosciences, LLC, Molzym GmbH & Co. KG, BioSpherex LLC, and Diversigen. Metagenomics has witnessed significant research funding in past few years driving opportunities in functional characterization, disease biomarker discovery and drug development using microbiome data. Major companies are expanding globally through acquisitions and partnerships to strengthen their share in the high growth Microbiome Sequencing Service Market Demand.

The rising number of metagenomics projects and multi-omic research initiatives provide key opportunities in microbiome sequencing service market. Companies are focusing on expanding their geographic presence in high growth regions such as Asia Pacific and Europe through acquisitions and collaborations with local research institutes. This will help companies to gain deeper insights on regional microbiomes and their impact on human and environmental health.

Market Drivers and Restrain:

The key driver for microbiome sequencing service market is rising investments in metagenomics research. Metagenomics studies the collective genetic material recovered directly from environmental samples and studies complex microbial communities. With advancement in sequencing technologies, metagenomics provides a culture-independent approach to study whole microbial communities. This has led to surge in grant funding for metagenomics projects from both private and government sources globally. However, requirement of expensive instruments, dedicated bioinformatics support and high capital investment for building integrated sequencing pipelines are some key challenges restraining market growth. Data management and analyzing large sequencing data generated through metagenomics projects is a complex task requiring specialized bioinformatics expertise, which is currently limited. This poses challenge for widespread adoption of microbiome sequencing in clinical research and healthcare applications.

Segment Analysis

The Microbiome Sequencing Service Market is segmented by technology into 16S rRNA sequencing, metagenomics sequencing, and others. 16S rRNA sequencing is dominating the market currently as it is more cost-effective and easy to analyse and interpret the results compared to metagenomics sequencing. Metagenomics sequencing identifies all genetic material in a microbial community, which provides comprehensive insights but is more expensive and complex analysis.

Global Analysis

Regionally, North America holds the largest share in the Microbiome Sequencing Service Market due to growing applications of microbiome therapeutics for chronic disease management. The presence of major players and developed healthcare infrastructure are some key factors supporting market growth. Europe is the second largest region, while Asia Pacific is emerging as the fastest growing regional market owing to increasing R&D investments in microbiome research from pharmaceutical and biotechnology companies and rising awareness of microbiome-based therapies.

Get More Insights On- Microbiome Sequencing Service Market

Explore More Related Topic On- Alcohol Ethoxylates Market